Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Feuilhade

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Pathologie-Biologie|October 1, 1990
[Consensus and controversies in conservative treatment indications]E Calitchi, Y Otmezguine, F Feuilhade, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Management of breast cancer in the elderlyL M Martin, C le Pechoux, E Calitchi, et al.
Presse Medicale (Paris, France : 1983)|April 30, 1983
[Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases]B Brun, M Kuentz, N G Man, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Prognostic factors and treatment of multiple myeloma: interest of a cyclic sequential chemohormonotherapy combining cyclophosphamide, melphalan, and prednisoneD Belpomme, F Simon, P Pouillart, et al.
British Journal of Cancer|October 3, 1999
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)P Viens, T Palangié, M Janvier, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Pathologie-Biologie|October 1, 1990
[Consensus and controversies in conservative treatment indications]E Calitchi, Y Otmezguine, F Feuilhade, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Management of breast cancer in the elderlyL M Martin, C le Pechoux, E Calitchi, et al.
Presse Medicale (Paris, France : 1983)|April 30, 1983
[Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases]B Brun, M Kuentz, N G Man, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Prognostic factors and treatment of multiple myeloma: interest of a cyclic sequential chemohormonotherapy combining cyclophosphamide, melphalan, and prednisoneD Belpomme, F Simon, P Pouillart, et al.
British Journal of Cancer|October 3, 1999
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)P Viens, T Palangié, M Janvier, et al.
Pageof 5